{
    "title": "AstraZeneca to buy Actavis lung drugs as earnings fall short",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-2940679/AstraZeneca-buy-Actavis-lung-drugs-Q4-earnings-fall-short.html",
    "date": "2015-02-05",
    "keywords": [
        "percent",
        "year",
        "astrazeneca",
        "fall",
        "gmt",
        "drug",
        "growth",
        "soriot",
        "quarter",
        "core",
        "lung",
        "email",
        "ben",
        "hirschlerlondon",
        "thursday",
        "business",
        "canada",
        "fourthquarter",
        "earningsastrazeneca",
        "drugmaker",
        "mid",
        "exchange",
        "ratesbut",
        "share",
        "singledigit",
        "spending",
        "projectswell",
        "biotech",
        "company",
        "executive",
        "model",
        "costsharingthe",
        "analyst",
        "deliberate",
        "hit",
        "development",
        "clark",
        "profitsthe",
        "group",
        "bid",
        "pfizer",
        "shareindustry",
        "thomson",
        "respiratory",
        "acquisition",
        "july",
        "aclidinium",
        "agreement",
        "almirallrespiratory",
        "area",
        "jump",
        "track",
        "promising",
        "cancer",
        "profit",
        "pressure",
        "loss",
        "exclusivity",
        "arrival",
        "heartburn",
        "medicine",
        "nexium",
        "challenge",
        "reporting",
        "eps",
        "team",
        "reason",
        "management",
        "david",
        "merriman",
        "thomas"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}